Jaguar Health 배당금
배당금 기준 확인 0/6
Jaguar Health does not have a record of paying a dividend.
주요 정보
n/a
배당 수익률
-388.1%
환매 수익률
| 총 주주 수익률 | -388.1% |
| 미래 배당 수익률 | n/a |
| 배당금 성장 | n/a |
| 다음 배당금 지급일 | n/a |
| 전 배당일 | n/a |
| 주당 배당금 | n/a |
| 지급 비율 | n/a |
최근 배당금 업데이트
업데이트 없음
Recent updates
Jaguar Health, Inc. (NASDAQ:JAGX) Stock's 55% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 24
Jaguar Health, Inc. (NASDAQ:JAGX) Might Not Be As Mispriced As It Looks After Plunging 49%
May 24Jaguar Health, Inc. (NASDAQ:JAGX) Shares Fly 55% But Investors Aren't Buying For Growth
Mar 29Jaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 39%
Jan 22Positive Sentiment Still Eludes Jaguar Health, Inc. (NASDAQ:JAGX) Following 32% Share Price Slump
Jun 10Jaguar Health (NASDAQ:JAGX) Is Carrying A Fair Bit Of Debt
Jan 23Jaguar Health rises 19% on orphan drug tag for congenital diarrheal disorder treatment
Oct 17Jaguar Health sells crofelemer and lechlemer royalty rights for $4M upfront
Aug 25Jaguar Health gets 180-day grace period to regain compliance with Nasdaq's listing rule
Aug 19Jaguar Health rises on U.S. patent for treating chemotherapy-induced diarrhea
Aug 09Jaguar stock rises on license deal with SynWorld for Canalevia in China
Jun 29Jaguar Health CEO Lisa Conte - From Rainforest To Laboratory
Mar 07Jaguar Health shares jumps 13% after pricing $15M direct offering
Jan 13Jaguar Health plans for conditional marketing application in Europe for Crofelemer, initially for Long-Hauler COVID-19 patients
Jan 11Jaguar Health leaps higher in new year
Jan 05Jaguar Health inks second Mytesi royalties agreement for $6M
Dec 23Does Jaguar Health (NASDAQ:JAGX) Have A Healthy Balance Sheet?
Dec 02
Jaguar Health's crofelemer development nears SPAC funding in Europe, shares +61%
Nov 30Jaguar Health EPS misses by $0.10, misses on revenue
Nov 16Jaguar Health receives positive Nasdaq listing determination
Oct 29결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: Insufficient data to determine if JAGX's dividends per share have been stable in the past.
배당금 증가: Insufficient data to determine if JAGX's dividend payments have been increasing.
시장 대비 배당 수익률
| Jaguar Health 시장 대비 배당 수익률 |
|---|
| 세그먼트 | 배당 수익률 |
|---|---|
| 회사 (JAGX) | n/a |
| 시장 하위 25% (US) | 1.5% |
| 시장 상위 25% (US) | 4.5% |
| 업계 평균 (Pharmaceuticals) | 2.3% |
| 애널리스트 예측 (JAGX) (최대 3년) | n/a |
주목할만한 배당금: Unable to evaluate JAGX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
고배당: Unable to evaluate JAGX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
주주에 대한 수익 배당금
수익 보장: Insufficient data to calculate JAGX's payout ratio to determine if its dividend payments are covered by earnings.
주주에 대한 현금 배당금
현금 흐름 범위: Unable to calculate sustainability of dividends as JAGX has not reported any payouts.